Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...
Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...
Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Natuurkundige <strong>voor</strong>drachten I Nieuwe reeks 89<br />
Migraine: de ontrafeling van een complexe ziekte<br />
112<br />
sias) and negative (e.g., scotomata, paresis) phe-<br />
<strong>no</strong>mena of the migraine aura can be well explained<br />
by the biphasic nature of CSD, in which the neuronal<br />
depression is frequently preceded by transient<br />
hyperexcitability. Most importantly however, functional<br />
neuroimaging studies have demonstrated<br />
that the changes in CBF during a migraine aura are<br />
highly reminiscent of those observed in experimental<br />
animals during CSD. Using functional MRI,<br />
Hadjikhani and colleagues found a focal increase in<br />
the blood oxygen level-dependent (BOLD) signal that<br />
spread through the occipital cortex at a rate of 3.5<br />
mm/min. The direction and speed of the spread were<br />
in agreement with the visual experiences reported by<br />
the patient, and the increased BOLD signal was followed<br />
by a decrease in signal. This pattern would be<br />
consistent with a brief initial rise in CBF followed by a<br />
longer-lasting decrease in blood flow.<br />
C. CSD as the trigger of the headache phase<br />
Despite mounting evidence that CSD underlies<br />
the migraine aura, it remains unclear whether CSD<br />
may trigger the headache phase itself, perhaps via<br />
activation of the trigemi<strong>no</strong>vascular system. Animal<br />
experiments have provided evidence in support<br />
of this hypothesis. For example, high K + -induced<br />
CSD in the rat parietal cortex can activate ipsilateral<br />
trigeminal nucleus caudalis neurons and cause<br />
long-lasting elevated blood flow in the middle<br />
meningeal artery, as well as dural plasma protein<br />
leakage that can be inhibited by ipsilateral trigeminal<br />
nerve resection. Moreover, treatment with several<br />
classes of migraine prophylactic drugs inhibits<br />
experimentally induced CSDs as measured with<br />
electrophysiology and cerebral blood flow. In contrast<br />
to animal studies, the connection between<br />
CSD and the headache phase in patients remains an<br />
open question. Goadsby reviewed the mainly clinical<br />
arguments against the hypothesis that CSD may<br />
also trigger headache mechanisms. First, only one<br />
third of migraineurs report having auras, raising the<br />
question of how the headache phase is triggered in<br />
patients without aura. One possible explanation is<br />
that all migraineurs might indeed have SD, but that<br />
perhaps MO patients exhibit (C)SD in clinically silent<br />
subcortical areas of the brain without propagating<br />
to the visual cortex. Although formally possible,<br />
this hypothesis is difficult to test directly; however,<br />
one case reported spreading cerebral hypoperfusion<br />
during the headache phase in an MO patient.<br />
Second, the aura and the headache phase would<br />
be predicted to occur on opposite sides if CSD activates<br />
the trigemi<strong>no</strong>vascular system, but in some<br />
cases the headache can occur on the same side as<br />
the aura. Third, in some cases aura can occur after<br />
the headache has started, suggesting that it might<br />
<strong>no</strong>t serve to trigger the headache. Fourth, aura is<br />
<strong>no</strong>t unique to migraineurs. For example, auras have<br />
been reported with attacks of cluster headache, paroxysmal<br />
hemicrania and hemicrania continua.<br />
Finally, treatment with intranasal ketamine has<br />
been reported to abort migraine aura but failed to<br />
prevent the headache phase. Yet despite these arguments,<br />
the exact role, if any, that spreading depression<br />
plays in triggering migraine headache mechanisms<br />
remains unclear and the subject of intense<br />
investigation.<br />
IV. MIGRAINE AS A GENETIC DISORDER<br />
A. Genetic epidemiology of migraine<br />
There is considerable evidence to support the <strong>no</strong>tion<br />
that migraine has an underlying genetic basis. First,<br />
migraine frequently runs in families, and population-based<br />
studies have confirmed that the risk of<br />
migraine in first-degree relatives is 1.5- to 4-fold<br />
greater than in <strong>no</strong>nrelated individuals. This familial<br />
risk is highest for MA patients, with a young age of<br />
onset and a high attack severity and disease disability.<br />
Using the basis of differing estimates of heritability,<br />
some reports have suggested that MA and MO<br />
are different entities. However, several arguments<br />
suggest instead that the aura component may have<br />
some heritable biological distinction. For example,<br />
many migraineurs experience both MA and MO<br />
attacks throughout their lifetime, for example, MA<br />
in childhood, MO in young adulthood, and MA again<br />
in later life. Furthermore, an Australian study of<br />
more than 6000 twin pairs used the basis of the patterns<br />
and severity of migraine symptoms to identify<br />
disease subtypes (‘latent classes’), arguing against